Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes have?
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes has 3,655 citations in the OpenAlex counts ScholarIQ stores.
When was Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes published?
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes has 2016 year in the ScholarIQ index.
What is the open-access status of Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes?
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes?
The DOI for Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes is on the source record.
What is the PMID of Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes?
The PMID for Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes is on the source record.
What is the OpenAlex record for Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes?
The OpenAlex for Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes is on the source record.